Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q2

2796.TEDINET S100PYDZ
Period2022-06-01 → 2022-11-30
Filed2023-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥25.7bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥25.9bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income¥573m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥788m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income¥566m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥814m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥394m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥775m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)¥72m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥250m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income¥77m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥254m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥23.3bnat 2022-11-30Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.2bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥16.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.7bnat 2022-11-30Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.5bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥4.3bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥4.3bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥3.3bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥713m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥448m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥292m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥337m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥792m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.0bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.0bn2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥7.762022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.082022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.942021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.092021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥5.932022-06-01 → 2022-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥20.342021-06-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio27.4%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.8%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2022-11-30¥375m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2022-11-30¥375m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2022-11-30¥26m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥153m
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2022-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2022-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2022-11-30−¥129m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2022-11-30¥328m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2022-11-30¥328m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2022-11-30¥38m
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2022-11-30¥20.9bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2022-11-30¥20.9bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2022-11-30¥744m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥45m
—segment totalrevenue2022-06-01 → 2022-11-30¥25.4bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥25.4bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥699m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥25.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥25.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥726m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2021-11-30¥437m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2021-11-30¥437m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2021-11-30¥13m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥155m
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2021-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2021-11-30¥3.9bn
jpcrp040300-q2r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2021-11-30−¥101m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2021-11-30¥346m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2021-11-30¥346m
jpcrp040300-q2r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2021-11-30¥59m
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2021-11-30¥21.0bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2021-11-30¥21.0bn
jpcrp040300-q2r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2021-11-30¥938m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-11-30¥252m
jpcrp040300-q2r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-11-30¥32m
—segment totalrevenue2021-06-01 → 2021-11-30¥25.5bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥25.5bn
—segment totalsegment profit2021-06-01 → 2021-11-30¥929m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥25.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥25.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥943m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 552
ItemContextValueUnit
Other caPrior1YearInstant319000000JPY
Other caCurrentQuarterInstant329000000JPY
Allowance for doubtful accounts caPrior1YearInstant-5000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-5000000JPY
Current assetsPrior1YearInstant10878000000JPY
Current assetsCurrentQuarterInstant10724000000JPY
Buildings and structures netPrior1YearInstant3121000000JPY
Buildings and structures netCurrentQuarterInstant3004000000JPY
LandPrior1YearInstant2616000000JPY
LandCurrentQuarterInstant2603000000JPY
Other net ppePrior1YearInstant617000000JPY
Other net ppeCurrentQuarterInstant607000000JPY
Property plant and equipmentPrior1YearInstant6355000000JPY
Property plant and equipmentCurrentQuarterInstant6214000000JPY
GoodwillPrior1YearInstant3220000000JPY
GoodwillCurrentQuarterInstant3093000000JPY
Other iaPrior1YearInstant409000000JPY
Other iaCurrentQuarterInstant399000000JPY
Intangible assetsPrior1YearInstant3629000000JPY
Intangible assetsCurrentQuarterInstant3492000000JPY
Other ioaPrior1YearInstant3045000000JPY
Other ioaCurrentQuarterInstant3027000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-164000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-152000000JPY
Investments and other assetsPrior1YearInstant2881000000JPY
Investments and other assetsCurrentQuarterInstant2874000000JPY
Noncurrent assetsPrior1YearInstant12866000000JPY
Noncurrent assetsCurrentQuarterInstant12581000000JPY
Deferred assetsPrior1YearInstant1000000JPY
Deferred assetsCurrentQuarterInstant0JPY
AssetsPrior1YearInstant23746000000JPY
AssetsCurrentQuarterInstant23306000000JPY
Accounts payable tradePrior1YearInstant4109000000JPY
Accounts payable tradeCurrentQuarterInstant4281000000JPY
Current portion of bondsPrior1YearInstant－JPY
Current portion of bondsCurrentQuarterInstant1482000000JPY
Current portion of long term loans payablePrior1YearInstant2276000000JPY
Current portion of long term loans payableCurrentQuarterInstant2044000000JPY
Income taxes payablePrior1YearInstant429000000JPY
Income taxes payableCurrentQuarterInstant312000000JPY
Provision for bonusesPrior1YearInstant46000000JPY
Provision for bonusesCurrentQuarterInstant42000000JPY
Provision for loss on store closingPrior1YearInstant50000000JPY
Provision for loss on store closingCurrentQuarterInstant48000000JPY
Other clPrior1YearInstant1564000000JPY
Other clCurrentQuarterInstant1631000000JPY
Current liabilitiesPrior1YearInstant8477000000JPY
Current liabilitiesCurrentQuarterInstant9842000000JPY
Bonds payablePrior1YearInstant1482000000JPY
Bonds payableCurrentQuarterInstant－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass